Search

everythinglearnresearchcommunity

for

Search:↓

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Setipiprant did not significantly improve hair growth in men with hair loss.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Different doses of triamcinolone injections work equally well for skin conditions.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Upadacitinib may effectively treat alopecia areata without side effects.